SCHEMBL3942301

SCHEMBL3942301

COc1ccc(CCNC(=O)c2[nH]c3ccc(NS(=O)(=O)c4ccc(C(C)(C)C)cc4)cc3c2-c2ccccc2)cc1OC

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.55
ALDH1A1 P00352 2/20 0.55
MAPT P10636 3/20 0.49
TP53 P04637 1/20 0.47
POLB P06746 1/20 0.47
SERPINE1 P05121 1/20 0.46
BRD4 O60885 1/20 0.46
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
CA14 Q9ULX7 1/20 0.45
MEN1 O00255 2/20 0.44
LMNA P02545 1/20 0.44
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALPL P05186 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3947203 0.90 SERPINE1 (0.54) KMT2AALDH1A1MAPTPOLBSERPINE1
SCHEMBL3946949 0.89 SERPINE1 (0.49) KMT2AALDH1A1MAPTPOLBSERPINE1
SCHEMBL3943857 0.88 KMT2A (0.50) KMT2AALDH1A1MAPTTP53POLB
SCHEMBL3949349 0.88 CNR1 (0.55) ALDH1A1MAPTPOLBSERPINE1BRD4
SCHEMBL3946187 0.87 BRD4 (0.52) KMT2AALDH1A1POLBSERPINE1BRD4
SCHEMBL3945245 0.87 SERPINE1 (0.51) KMT2AALDH1A1MAPTPOLBSERPINE1
SCHEMBL3951583 0.85 SERPINE1 (0.53) KMT2AALDH1A1MAPTPOLBSERPINE1
SCHEMBL3951018 0.85 BRD4 (0.52) KMT2AALDH1A1MAPTPOLBSERPINE1
SCHEMBL3949722 0.85 BRD4 (0.54) KMT2AALDH1A1MAPTPOLBSERPINE1
SCHEMBL3943094 0.85 BRD4 (0.54) KMT2AALDH1A1MAPTPOLBSERPINE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1802572-B1 INDOL DERIVATIVES AS INHIBITORS OF SOLUBLE ADENYLYL CYCLASE BAYER SCHERING PHARMA AG (DE) 2009-04-22 EP claimed
US-20080004268-A1 INHIBITORS OF SOLUBLE ADENYLATE CYCLASE NGUYEN DUY 2008-01-03 US disclosed
US-20080004268-A1 INHIBITORS OF SOLUBLE ADENYLATE CYCLASE NGUYEN DUY 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004268-A1 INHIBITORS OF SOLUBLE ADENYLATE CYCLASE ADCY1, ADCY2, ADCY5 KMT2A 4518/4885ALDH1A1 268/4885MAPT 4671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.